Waiting
Elaborazione accesso...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / Profilering af følsomhed over for målrettede…
JoVE Journal
Cancer Research

Questo Contenuto è ad Accesso gratuito.

JoVE Journal Cancer Research
Profilering af følsomhed over for målrettede terapier i EGFR-mutant NSCLC-patientafledte organoider
 
Click here for the English version

Profilering af følsomhed over for målrettede terapier i EGFR-mutant NSCLC-patientafledte organoider

Article DOI: 10.3791/63039-v • 08:52 min • November 22nd, 2021
November 22nd, 2021 •
1,2,3, 1,2, 1,2,3, 1,2,3
1Department of Medicine, University of California, San Francisco, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 3Department of Cellular and Molecular Pharmacology, University of California, San Francisco

Capitoli

Riepilogo
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Denne protokol beskriver en standardiseret evaluering af lægemiddelfølsomheder over for målrettede signalhæmmere i NSCLC-patientafledte organoidmodeller.

Tags

Kræftforskning udgave 177 Organoid lungeorganoid BOB NSCLC lungekræft osimertinib EGFR målrettet hæmmer resistens
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter